TMC
CDNA icon

Trellus Management Company’s CareDx CDNA Stock Holding History

Trellus Management Company’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,156
Closed -$100K – 72
2017
Q3 		$100K Buy
+27,156
New +$57K 0.14% 73

Other funds holding CDNA

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Trellus Management Company's CDNA Position: Q4 2017 in Review

Trellus Management Company sold out of CareDx (CDNA) in Q4 2017, closing a stake of 27,156 shares — an estimated $100K sold.

Trellus Management Company first reported a position in CDNA in Q3 2017 and held it in 1 quarter. The position peaked at $100K in Q3 2017. 59 funds tracked by Wall St. Rank hold CDNA as of Q4 2017.

  • Trellus Management Company reported no remaining CareDx position as of Q4 2017 after selling out during the quarter.
  • Trellus Management Company sold 27,156 CareDx shares in Q4 2017, an estimated $100K.
  • Trellus Management Company first reported a position in CareDx in Q3 2017 and held it in 1 quarter.
  • Trellus Management Company's CareDx position peaked at $100K in Q3 2017.
  • 59 funds tracked by Wall St. Rank held CareDx as of Q4 2017.

Based on Trellus Management Company's 13F filing for Q4 2017, filed 2 Feb 2018.